LIPID PROFILE AND ANTIOXIDANT ASSESSMENT OF CAFFEINE INDUCED ALBINO RATS TREATED WITH NIFEDIPINE

Fatai A. Kareem, Ademola O. Akinyemi, Anuoluwapo O. Ajayi & Naomi A. Folorunsho , August 2022, Published: 2022-08-28

Hypertension is a chronic elevation of blood pressure that, in the long-term results in increased morbidity and mortality. The present study investigates the effectiveness of 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4- dihydropyridine-3,5-dicarboxylate (nifedipine) on lipid profile and antioxidant level of caffeine induced hypertensive albino rats. Twenty-one adult albino rats weighing between 100 and 200g were grouped into three consisting of seven animals each. The control group were fed and orally administered with normal saline, the model and treatment groups were fed and given body weight 100 mg/Kg of caffeine orally for three days while the treatment group was administered with 2ml/kg body weight of nifedipine orally for three days. The blood pressure and body weight were measured accordingly. The animals were sacrificed twenty-four (24) hours after the last administration. The blood sample was collected for assay. There was increase in body weight and blood pressure of the model group when compared with the control while it was restored in the treatment group. The results revealed an increase in total cholesterol and low density lipoprotein level in the model group and restoration in the treatment group. The atherogenic index of the plasma, Castelli’s risk index I and II and atherogenic coefficient were increased in the model group while it was restored in the treatment group. There was reduced antioxidants level in the model group and the antioxidants were restored in the treatment group. This study confirmed the antihypertensive potential of nifedipine and therefore can be used as a strong therapy for hypertension with minimum side effects. Keywords: Antioxidant, blood pressure, calcium-channel blocker, hypertension and lipid profile
Back